Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices

Published:2018-02 Issue:2 Volume:41 Page:86-95
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Cowey C. Lance,Liu Frank Xiaoqing,Black-Shinn Jenny,Stevinson Kendall,Boyd Marley,Frytak Jennifer R.,Ebbinghaus Scot W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference37 articles.

1. Analysis of trends in US melanoma incidence and mortality;Glazer;JAMA Dermatol,2016

2. Cutaneous melanoma;Eggermont;Lancet,2014

3. Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study;Middleton;Cancer Med,2016

4. Evolving therapeutic strategies maintain clinical momentum in melanoma;De Lartigue;J Commun Support Oncol,2016

5. Immune checkpoint inhibitors: a milestone in the treatment of melanoma;Wilden;J Dtsch Dermatol Ges,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review;Cancers;2022-12-12

2. Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review;European Journal of Cancer;2022-11

3. Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany;Cancers;2022-04-01

4. The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma;Biomedicines;2022-03-31

5. Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs;ESMO Open;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3